<DOC>
	<DOCNO>NCT00834171</DOCNO>
	<brief_summary>Patient chart review evaluate incidence intraocular pressure spike Loteprednol etabonate ophthalmic suspension 0.5 % , Loteprednol etabonate ( 0.5 % ) tobramycin ( 0.3 % )</brief_summary>
	<brief_title>A Retrospective Evaluation Intraocular Pressure Spikes With Loteprednol Loteprednol/Tobramycin</brief_title>
	<detailed_description />
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Tobramycin</mesh_term>
	<mesh_term>Loteprednol Etabonate</mesh_term>
	<criteria>Any patient experience IOP spike use Lotemax Zylet include</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>